Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
27.43
0.17 (0.62%)
At close: Aug 18, 2025, 3:59 PM
27.01
-1.53%
Pre-market: Aug 19, 2025, 08:02 AM EDT
Nektar Therapeutics Revenue
Nektar Therapeutics reported an annual revenue of $98.43M, reflecting a 9.22% growth. For the quarter ending June 30, 2025, Nektar Therapeutics generated $11.18M in revenue.
Revenue (ttm)
98.43M
Revenue Growth
9.22%
Price / Sales Ratio
1.94
Revenue / Employee
1.61M
Employees
61
Market Cap
521.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 98.43M | +9.22% |
Dec 31, 2023 | 90.12M | -2.10% |
Dec 31, 2022 | 92.06M | -9.67% |
Dec 31, 2021 | 101.91M | -33.36% |
Dec 31, 2020 | 152.91M | +33.41% |
Dec 31, 2019 | 114.62M | -90.40% |
Dec 31, 2018 | 1.19B | +287.81% |
Dec 31, 2017 | 307.71M | +86.00% |
Dec 31, 2016 | 165.44M | -28.32% |
Dec 31, 2015 | 230.78M | +14.99% |
Dec 31, 2014 | 200.71M | +34.77% |
Dec 31, 2013 | 148.92M | +83.42% |
Dec 31, 2012 | 81.19M | +13.59% |
Dec 31, 2011 | 71.48M | -55.06% |
Dec 31, 2010 | 159.04M | +121.10% |
Dec 31, 2009 | 71.93M | -20.24% |
Dec 31, 2008 | 90.19M | -66.97% |
Dec 31, 2007 | 273.03M | +25.40% |
Dec 31, 2006 | 217.72M | +72.41% |
Dec 31, 2005 | 126.28M | +10.51% |
Dec 31, 2004 | 114.27M | +7.54% |
Dec 31, 2003 | 106.26M | +12.03% |
Dec 31, 2002 | 94.84M | +22.43% |
Dec 31, 2001 | 77.47M | +50.05% |
Dec 31, 2000 | 51.63M | +24.83% |
Dec 31, 1999 | 41.36M | +89.76% |
Dec 31, 1998 | 21.8M | +34.13% |
Dec 31, 1997 | 16.25M | +135.49% |
Dec 31, 1996 | 6.9M | +102.94% |
Dec 31, 1995 | 3.4M | +100.00% |
Dec 31, 1994 | 1.7M | n/a |